PureCircle to expand the use of its latest stevia leaf varietal
PureCircle has developed and is now expanding the use of a new stevia leaf variety designed to yield greater quantities of stevia ingredients from each leaf.
Photo © iStockphoto.com/ olm26250
PureCircle (Chicago, IL) has developed and is now expanding the use of a new stevia leaf variety designed to yield greater quantities of stevia ingredients from each leaf, improving the company’s production efficiency, and its ability to provide a sustainable supply of stevia leaf ingredients. This year, 20% of PureCircle’s stevia plants were comprised of this new variety, though the company has plans to switch 90% of its stevia crop to this variety in 2020. PureCircle works with farmers in Asia, Africa, Latin America, and North America to grow and source the proprietary stevia plants.
“We are excited about our expansion program for our latest stevia varietal. It is the result of, and a testament to, our world-class agronomy and innovation,” said Maga Malsagov, CEO of PureCircle, in a press release. “This further enhances our ability to provide food and beverage companies access to the best tasting content from the leaf, offering them a globally scaled supply and a cost-efficiency which has never before been possible.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
